Fridays review

Fridays for moms: our verdict

Under every price on this site sit four words: "Paid annually, delivered monthly." The $117 and $150 and $198 in the headlines are what twelve months paid today works out to per month. If you would rather pay as you go — the sensible choice with a medication you may not tolerate — compounded semaglutide is $249 and tirzepatide $359, and to Fridays' credit both are printed. What is worth a second look is the "96.8% success rate" beside the before-and-after photos: the footnote says it measures deliveries. It runs about $249/mo — pricier than the category, so the extras have to earn it.

We looked at Fridays the way moms actually have to: not just the monthly cost, but the right timing around pregnancy and nursing and honest, clear pricing from the start — the parts a generic weight-loss review skips.

What Fridays actually costs

• Compounded semaglutide — Month to month: $249/mo
• Compounded semaglutide — Prepaid annual plan: $150/mo
• Compounded tirzepatide — Month to month: $359/mo
• Compounded tirzepatide — Prepaid annual plan: $240/mo
• Brand-name semaglutide — Ozempic, month to month: $1498/mo
• Brand-name tirzepatide — Zepbound, month to month: $1828/mo

For context, the typical ongoing price on our list is around $177/mo, so Fridays sits at the pricier end.

That price covers the consult, the medication, shipping and coaching.

The medications Fridays prescribes

Fridays lists semaglutide and tirzepatide. Offering both gives a prescribing clinician options, but PCOS or a history of gestational diabetes alone does not establish which medication is right for you. It can point you toward FDA-approved brand-name medications as well as the compounded versions — approved products carry the manufacturer's own pregnancy and breastfeeding label, which is cleaner to hand to an OB-GYN.

If you prefer an option without needles, check the exact product offered. FDA-approved oral semaglutide tablets have their own clinical trials and prescribing labels. Compounded oral or sublingual products are different: they are not FDA-approved and cannot be assumed equivalent to an approved tablet or injection. Ask the clinician about the formulation, evidence and instructions.

Where it operates. Fridays lists its coverage as: Not published on the site.

Where Fridays fits — and where it doesn't — for moms

A good fit if…

• you want a real clinician who reads your history with the right timing around pregnancy and nursing in mind, not a questionnaire that approves you automatically.
• you want to discuss both semaglutide and tirzepatide with your prescribing clinician.

Look elsewhere if…

• you need to bill insurance — like almost all of this market, it's cash-pay.

Trust, safety and oversight

Our confidence is moderate — the core data holds up, but some details (state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing moms can do is confirm which licensed pharmacy fills the prescription and what's in the formula — we explain how we score oversight in our scoring methodology.

Pregnancy and breastfeeding need separate discussions with your clinician. GLP-1 weight-loss treatment is not recommended during pregnancy. During breastfeeding, the exact drug and formulation matter: Wegovy tablets are not recommended because of the SNAC absorption ingredient. Injectable semaglutide and tirzepatide labels call for weighing benefits, risks and the limits of infant-safety data; they do not establish that treatment is safe for every nursing parent. Compounded products do not inherit FDA approval from the branded drug. Discuss your own medication and timing before starting or changing treatment.

The bottom line

Fridays is a reasonable option — weigh it on the right timing around pregnancy and nursing and honest, clear pricing from the start against the alternatives below. For moms comparing another compounded offer, CoreAge Rx describes prices and terms to confirm for the selected dose and plan.